Brief: Surrozen Provides First Quarter 2023 Financial Results And Corporate And Pipeline Updates
May 10 (Reuters) - Surrozen Inc SRZN.O :
* SURROZEN PROVIDES FIRST QUARTER 2023 FINANCIAL RESULTS AND
CORPORATE AND PIPELINE UPDATES
* SURROZEN - ENROLLMENT ONGOING IN SZN-1326 PHASE 1A
CLINICAL
TRIAL IN HEALTHY VOLUNTEERS WITH SAFETY DATA EXPECTED BY END OF
2023
* SURROZEN INC - QTRLY LOSS PER SHARE $0.48
Source text for Eikon: ID:nGNX9ssRyL
Further company coverage: SRZN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surrozen
See all newsBrief: Surrozen Announces Closing Of Second Tranche Of March 2025 Private Placement For $95.1 Million
Surrozen, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Surrozen Q2 Operating Income USD -10.37 Million
Surrozen, Inc. expected to post a loss of $1.29 a share - Earnings Preview
Brief: Surrozen Q1 EPS USD -11.65